Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease - Wikidata - wikimedia - TriplyDB

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

http://www.wikidata.org/entity/Q35442728

about

Cognitive profile of LRRK2-related Parkinson's disease Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Cellular processes associated with LRRK2 function and dysfunction The Role of α-Synuclein and LRRK2 in Tau Phosphorylation.The relevance of pre-motor symptoms in Parkinson's disease.Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD.Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.α-Synuclein and Parkinsonism: Updates and Future Perspectives.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Selective neuronal vulnerability in Parkinson disease.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Animal models of α-synucleinopathy for Parkinson disease drug development.Multisystem Lewy body disease and the other parkinsonian disorders.LRRK2 variation and dementia with Lewy bodies.Cautionary optimism: caffeine and Parkinson's disease risk.Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.Abolishing the 1-year rule: How much evidence will be enough?Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.Progression in the LRRK2-Asssociated Parkinson Disease Population.The LRRK2 signalling system.Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.Prying into the Prion Hypothesis for Parkinson's Disease.Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?Sleep aspects on video-polysomnography in LRRK2 mutation carriers.REM sleep behavior disorder and neuropathology in Parkinson's disease.LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.Hypercholinergic activity in LRRK2 Parkinson's disease.Neuropathology of Parkinson disease.Emerging Disease-Modifying Strategies Targeting α-Synuclein for the Treatment of Parkinson Disease.

P2860

Q27333093-D97D3DBF-0B9E-42DF-9FC7-6F4598E57B06 Q29048624-0378EF60-DB79-40E6-83D0-A8BF93849A7B Q33561039-2CF3729B-647E-4BDC-B834-021FDFBEB31D Q35692655-DE1137D8-8C0F-480D-9106-C54C415A6DFE Q36373170-63B5DAB1-1FF5-423A-B671-0877B42BA927 Q36470291-2BC6EBAB-2E8A-47B8-B92D-B9E4486C0814 Q37701053-B9BFB3E7-A59C-4DA8-9FD2-9E37CE9F3DA8 Q38433725-37F34146-EDAC-4298-A590-27894DCF3B1E Q38482479-C06D439E-8AEC-4EE3-B770-8EB051B906D5 Q38594857-047E6F9A-3DF0-46AD-AEAF-3B60642BF925 Q38702118-20D0C8DF-16FF-4647-8BF0-2C0F43FD1D2E Q38738200-3F78A94F-59F8-47A4-BC67-D07757743E8D Q38742153-B0F073C0-8BE9-43D5-926E-208703EAC7B9 Q38752945-7553F663-C257-4EB2-9705-5B3FC944348C Q38843010-1001831F-B662-4D26-B966-5D4BDADF158E Q38859352-7D966BB1-0D6A-429F-8887-11F002596E4F Q39095738-7EBDE251-1932-43E0-BE7D-B8EEE9170454 Q39206423-85EEFD63-08B0-49A3-A3EE-09149C4D44C3 Q40106906-6C88ADFA-E41E-46E3-AF47-56C1148D8A5C Q40260539-96B41511-FE85-4AC6-8FF9-E559D7D0CB08 Q41655722-6A6359D7-4D7A-4CB4-9063-00680807054D Q42740862-50CD41C9-FF34-4E96-AD33-7B13F42044C1 Q46341748-6BF1B2E3-2D99-4EF7-A575-399A9D56EDE9 Q46524557-BA6EFB4E-CA35-4942-8160-3C465B81A56B Q47139141-CAF44B36-AADC-40BC-B579-786BDB6F6DF2 Q47161677-ED7F7757-FDCF-43A0-B014-0429400256D4 Q47198236-D50D9994-3C0D-4FCC-BA10-D6F010F61AD8 Q47225650-69F822AF-DE22-46AC-BA94-FDDD5E635746 Q47281413-E62BFF88-1829-41AE-B22F-5E8BEE98B9DC Q47619453-28511457-C379-4EBE-92D9-063AA59D218A Q47643867-D3D2CFAE-A95C-428E-86FC-CE73BDC6F391 Q47665674-C81F2DB5-EC18-4E66-A9C1-F2438766559E Q47790326-AC3EF89A-FB71-4E82-9991-1AE674F26051 Q47927139-4BDB94B2-CCAA-4FB6-AE0B-E68B99FE59D6 Q47947716-1D50C772-2675-4721-A7F7-09A7396269B6 Q48560989-49029C65-37DF-404E-B529-B46EA9A2E285 Q49886566-95AA5922-8F54-4E80-AA7A-86733CDD5EE1 Q49886569-4CA20E8A-0A81-4891-968C-F6C77BD7B54E Q50239680-1DCDF054-BE56-4EA3-89A5-2CAA65E81F87 Q52714245-1246DEFE-E4C9-4A53-B284-B5D7DE8DEE4E

P2860

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

http://www.wikidata.org/entity/Q35442728

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@ast

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@en

type

label

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@ast

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@en

altLabel

Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease

@en

prefLabel

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@ast

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@en

P1433

Q35442728-5946C299-ABEC-4268-A63E-9053E5A4FE4F

P1476

Q35442728-B91A12E2-D2B7-4AB8-A120-4A7F74B8F8B3

P2093

Q35442728-020577E0-4478-480A-BC20-89B7AD942744

Q35442728-0A1E89D3-F4C7-46F7-8D01-5293399316D3

Q35442728-0AF6C3DD-12C1-4656-A3F5-F97C01720D29

Q35442728-0CE6759F-86F6-4607-B14D-B31FC2FBC06C

Q35442728-2CAED1E9-0388-4BA8-A80A-AC563AEC6B6A

Q35442728-466F6FA7-474C-44FC-9FA4-F42F94DF043B

Q35442728-48EB0A11-D9D8-48F9-AD5A-46274B216686

Q35442728-4B581076-C211-4B28-84A6-4EDEF00C2C5A

Q35442728-4BA92148-1AE1-4EC7-A3CB-6A2A59E4F10B

Q35442728-54961428-DC94-49A1-88AF-FBE2C59D902F

P2860

Q35442728-1CEDD82C-57F0-4612-8CFC-6925038955FD

Q35442728-2F14D5A3-A814-45A3-BACF-C0E5DC2A01D0

Q35442728-423BF3C8-A29D-4A60-80E9-487E00D8CB9F

Q35442728-4CD062F5-3CC1-4C90-A104-C5069BF31150

Q35442728-58467825-1442-4AEC-B5D4-70D173955141

Q35442728-83B1415A-C041-4760-97D6-F896C73C03DF

Q35442728-90F20B7F-9E33-43E5-9E3E-28EF409B9852

Q35442728-9E716E58-42E2-4D23-9CF0-5AC726521FCF

Q35442728-B673D398-E94E-4D46-8807-2DED21C9D886

Q35442728-B90C97CA-2B2F-42AD-A7D8-CD86CE5C334E

P304

Q35442728-5C080373-04F4-4912-BE76-D289F21AF634

P31

Q35442728-9ECF810A-0605-4362-B2AD-66FDAD2072FB

P356

Q35442728-18682D09-D466-4921-8A08-EED5DD16DBAB

P407

Q35442728-782E278B-7780-4ACD-8DEC-AA1A5CCB9CFD

P433

Q35442728-59A0C554-E4F5-43AA-916E-576F098F4C31

P478

Q35442728-BA913C3B-FCAB-42FE-81F7-F8150D65B445

P50

Q35442728-11061109-BC98-4FB9-8A18-8A6FEF8015D9

Q35442728-1D6E089E-1E16-4F45-9669-412DF64CBEF5

Q35442728-41C07EA0-57C4-4E27-8512-7F60D0096C17

Q35442728-4FC3339D-326D-4673-914A-80BABD5DBC51

Q35442728-56AA19E9-E8F8-4521-92FD-03546BDAB485

Q35442728-5EC97A02-F794-40F2-B313-27F1D1A6E21A

Q35442728-87ACC36D-499D-4379-9427-42A0F9BCAB90

Q35442728-CCADA8F0-A239-44C5-A003-3ECF596D9511

Q35442728-DFC5826A-7DEA-4985-A18B-AAF06D8A824E

P577

Q35442728-E687C3BB-79D9-48D1-8D54-828486909BBF

P5875

Q35442728-19FF45BF-CF4E-4C3E-9CE4-7389A8EDE722

P698

Q35442728-89225E84-4BC2-4097-AF3E-9D9B76261752

P921

Q35442728-F808F564-D106-4433-86EC-01BFB2482A45

P932

Q35442728-1AEDCD9B-5C5C-4A21-85A1-0C1B2DC4ADDC

P356

JAMANEUROL.2014.2704

P1433

P1476

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

@en

P2093

A Jon Stoessl

http://www.w3.org/2001/XMLSchema#string

Adolfo López de Munain

http://www.w3.org/2001/XMLSchema#string

Andre Maues De Paula

http://www.w3.org/2001/XMLSchema#string

Andreas Puschmann

http://www.w3.org/2001/XMLSchema#string

Birgitt Schüle

http://www.w3.org/2001/XMLSchema#string

Carles Gaig

http://www.w3.org/2001/XMLSchema#string

Charles Duyckaerts

http://www.w3.org/2001/XMLSchema#string

Dennis W Dickson

http://www.w3.org/2001/XMLSchema#string

Howard I Hurtig

http://www.w3.org/2001/XMLSchema#string

Isidre Ferrer

http://www.w3.org/2001/XMLSchema#string

P2860

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

The Parkinson's complex: parkinsonism is just the tip of the iceberg

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.

Neuropathologic substrates of Parkinson disease dementia.

Parkin disease: a clinicopathologic entity?

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

P304

100-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2014.2704

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

Zbigniew K Wszolek

Connie Fernández-Cid Marras

Vincenzo Bonifati

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268507371

http://www.w3.org/2001/XMLSchema#string

P698

25401511

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4399368

http://www.w3.org/2001/XMLSchema#string